--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "IDV - IMAIOS DICOM Viewer" developer_entity: "IMAIOS SAS" bundle_id: "com.imaios.imaiosdicomviewer" app_store_id: "1444841062" category: "Medical" primary_platform: "ios" primary_monetization: "Free" offline_capable: false market_region: "US" platforms: "iOS & Android" app_last_updated: "2026-07-27" report_date: "2026-08-15" last_verified: "2026-08-15T00:00:00.000Z" report_version: "3.2.0" total_reviews: 2201 overall_rating: 4.2 sentiment: "Mixed" sentiment_score: 45 confidence: "high" confidence_score: 0.7 top_praise_theme: "Medical professionals find the mobile DICOM viewing capabilities reliable for reviewing patient scans on the go" top_complaint_theme: "Multi-planar reconstruction mode performance degraded significantly following the latest update, causing slow response times" review_sample_size: 50 total_review_count: 50 analyzed_review_count: 50 data_age_days: 1 momentum_velocity: "active" intelligence_version: 3 tags: ["medical", "free", "mixed sentiment", "mobile app", "app review", "app analysis", "medical", "students,", "radiology"] canonical_url: "https://marlvel.ai/apps/idv-imaios-dicom-viewer-1" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # IDV - IMAIOS DICOM Viewer Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Free - **Signal**: Rating 4.23 · Sentiment Mixed - **Recent focus**: Multi-planar reconstruction mode performance degraded significantly following the latest update, causing slow response times (top complaint) · Medical professionals find the mobile DICOM viewing capabilities reliable for reviewing patient scans on the go (top praise) > **TL;DR:** IDV - IMAIOS DICOM Viewer is a medical app by IMAIOS SAS, rated 4.23/5 by 2.2K users, with Mixed user sentiment (45/100), available on iOS & Android. > > **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence. > **Key Insight:** IDV - IMAIOS DICOM Viewer shows Mixed sentiment (4.23/5 from 2.2K reviews) - users praise medical professionals find the mobile dicom viewing capabilities reliable for reviewing patient scans on the go but report issues with multi-planar reconstruction mode performance degraded significantly following the latest update, causing slow response times. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 4.23/5 (2.2K reviews) | | **User Mood** | Mixed | | **Category** | Medical | | **Developer** | IMAIOS SAS | | **Pricing** | Free | | **Platforms** | iOS & Android | | **Confidence** | High (0.7/1.0) | | **Data Age** | 1d | ## Metadata & Market Performance - **Publisher:** IMAIOS SAS - **Category:** Medical - **Target Audience:** Medical students, radiology residents, and healthcare professionals requiring a portable, non-clinical tool for viewing medical images. - **Platforms:** iOS & Android - **Version Reviewed:** 3.3.0 - **Report Date:** 2026-08-15 - **Signal Count:** 50 reviews analyzed - **Confidence:** High (0.7/1.0) - **App Store ID (iOS):** 1444841062 - **Bundle ID:** com.imaios.imaiosdicomviewer - **Google Play ID:** com.imaios.imaiosdicomviewer - **Performance Trend:** Stable - **Data Window:** Analysis based on signals collected up to 2026-08-15 - **Short Description:** IDV is an application for viewing DICOM on Android. ## Executive Snapshot **What it is:** IDV - IMAIOS DICOM Viewer is a mobile tool for viewing and manipulating DICOM medical imaging files without cloud uploads. **Why users hire it:** It removes the connectivity and security friction associated with cloud-based medical imaging, serving as a portable reference tool for medical students and residents. ## App DNA (Features & Intent) - **[Differentiator] Local DICOM Processing:** Renders medical imaging files directly on the device without cloud uploads, removing server-side infrastructure costs. * *User Intent:* Users expect seamless access across multiple devices. - **[Standard] Image Manipulation Tools:** Provides scrolling, contrast adjustment, and measurement tools for DICOM files, reinforcing brand authority for the wider IMAIOS suite. * *User Intent:* Users seek enhanced value through premium features. - **[Differentiator] Online Web Viewer:** Provides a browser-based version of the viewer via the company website, creating a cross-platform funnel for paid services. * *User Intent:* Users seek enhanced value through premium features. ## Market Position {#market-position} IDV - IMAIOS DICOM Viewer maintains a presence across global medical charts, including #38 in Canada and #48 in Spain. The free-to-use model functions as an acquisition funnel for the publisher's professional education products rather than a standalone revenue driver. ## Monetization Strategy - **Model:** Free - **Tiers:** Completely free for personal and non-commercial use - **Analysis:** The app serves as a brand-building and acquisition channel for paid professional medical education products. ## 🟡 User Sentiment (High Confidence: 50 of 50 reviews analyzed) {#user-sentiment} - **Overall Rating:** 4.23/5 - **Platform Split:** iOS 4.7/5 (501 ratings) | Android 4.1/5 (1.7K ratings) - **Overall Sentiment:** Mixed ### Top Praises - **Medical professionals find the mobile DICOM viewing capabilities reliable for reviewing patient scans on the go** - **Cross-referencing tools between different image views help users analyze medical scans with greater clinical clarity** ### Top Complaints (Impact Areas) - **Multi-planar reconstruction mode performance degraded significantly following the latest update, causing slow response times** ## SWOT Analysis {#swot} **Core Strengths:** - Local-first processing architecture removes connectivity dependencies - Brand authority within the IMAIOS suite drives organic adoption **Growth Levers:** - Integration of Hounsfield unit measurements for diagnostic precision - Addition of horizontal and vertical image flipping tools ## Recent Changes (v2 → v3) {#recent-changes} The app's competitive positioning has sharpened, with the developer explicitly framing the lack of clinical certification as a strategic choice to avoid regulatory overhead. Market visibility has expanded to include regional rankings in Spain, while core performance complaints remain unresolved. **Overall trend**: Stable **Compared at**: 2026-08-15 ### High-impact changes - **[Shifted] Strategic Regulatory Positioning** (positioning) ### Medium-impact changes - **[Added] Expanded Market Visibility** (positioning) - **[Added] Explicit Monetization FAQ** (pricing) ## What's New - **Latest (v3.3.0, 1 months ago):** Added support for JPEG 2000 DICOM files and resolved issues with missing annotations in exported videos and toolbar visibility. ## App Momentum (Active) {#momentum} - Shipped JPEG 2000 codec support. - Resolved annotation export issues. > **Cadence:** 2 total versions · 2 majors in last 6 months · 19 days since last update · 12 days avg between updates ## The "So What?" (Strategic Takeaway) {#so-what} IDV - IMAIOS DICOM Viewer is a medical app that is completely free. With a 4.23/5 rating from 2.2K reviews, it shows mixed user reception. > **Bottom Line:** Restoring the ruler tool and reconstruction performance would address the primary churn drivers currently eroding the tool's utility for medical professionals. Prioritizing these stability fixes will protect the brand's reputation as a reliable reference tool for the wider IMAIOS suite. **Best for:** Medical students, radiology residents, and healthcare professionals requiring a portable, non-clinical tool for viewing medical images. ### PM Action Plan (Next Best Moves) - [ ] [PIVOT] Rebuild multi-planar reconstruction performance because lag is the top-cited frustration theme → restore daily active usage. ### Outlook: Mixed The mobile DICOM viewing market is consolidating around tools that offer reliable, high-performance local rendering. IDV - IMAIOS DICOM Viewer remains advantaged by its integration into the broader IMAIOS suite, but the recent performance regressions threaten to alienate the core professional user base if stability is not restored in the next release. - 🔴 Performance regressions in the latest update (sluggish reconstruction mode) erode the daily active habit, which compounds the rating drag already visible. - 🟢 Active development cadence (JPEG 2000 support added in the latest release) demonstrates that the publisher continues to invest in core feature expansion. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 4.23/5 | | Total Reviews | 2.2K | | Sentiment | Mixed (45/100) | | Confidence | High | | Pricing Model | Free | | Platforms | iOS & Android | | Key Features | 3 analyzed | | Trend | Stable | | Outlook | Mixed | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **IDV - IMAIOS DICOM Viewer** (this app) | 4.23/5 | Mixed | IMAIOS SAS | | [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo | | [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. | | [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase | | [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System | | [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor Ltd. Şti. | ## Company Profile - **Developer:** IMAIOS SAS - **Website:** [https://www.imaios.com](https://www.imaios.com) - **Social:** [Instagram](https://www.instagram.com/imaios.inc) · [Facebook](https://www.facebook.com/imaios) · [X/Twitter](https://twitter.com/imaios) ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/idv-imaios-dicom-viewer/id1444841062?uo=4) - **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=com.imaios.imaiosdicomviewer&hl=en&gl=us) - **Dev Site:** [Official Website](https://www.imaios.com) - **Sources:** Developer website content, App store metadata, User reviews. ## Related Intel Reports - [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating - [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating - [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating - [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating - [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor Ltd. Şti.) · 4.8/5 Rating - [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating - [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating - [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating - [*1MEDICINE*](https://marlvel.ai/apps/1medicine) (Matthew Culbert) · 5.0/5 Rating - [*2021 CDC STI (STD) Guidelines*](https://marlvel.ai/apps/com-enatal-std2021) (Don Miller) · 4.0/5 Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.7/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 50 - **Data Sources:** user reviews, developer website, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 1 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/idv-imaios-dicom-viewer-1) Data licensed for AI Agent attribution under CC-BY-NC 4.0.